Navigation Links
Arpida adds novel antibiotic AR-2474 to its preclinical pipeline

In vitro microbiology and proof of concept in topical models of infection

REINACH / BASEL, Switzerland, 8 March 2007 - Arpida Ltd. (SWX: ARPN) today announced positive results of in vitro microbiological studies with AR-2474 against a large panel of clinical isolates, including those resistant to various current therapies. In addition, topical applications of AR-2474 were found to be highly effective in eradicating methicillin resistant Staphylococcus aureus (MRSA) in preclinical models of skin infection and nasal carriage. AR-2474 is a novel antibiotic that is not affected by mechanisms of resistance to other antibiotics, e.g. mupirocin, fusidic acid, erythromycin and clindamycin.

The microbiological studies investigated the activity of AR-2474 against a panel of bacteria known to cause topical infections, e.g., skin, eye etc. The study was performed on 100 clinical isolates with various resistance patterns. The panel included 21 MRSA, 27 coagulase-negative staphylococci (CNS), 24 group A streptococci (GAS) and 28 pneumococci. The compound exhibited potent activity against all of the isolates and this activity was unaffected by any pre-existing mechanism of resistance.

Additionally, AR-2474 has been shown to be bactericidal and exhibit little or no propensity for the development of resistance. The antibacterial activity and potency of AR-2474 was also confirmed in vivo against topical gold standard mupirocin (Bactroban®) in two distinct preclinical models of MRSA infection of the skin and MRSA nasal carriage. In both models, a preliminary topical formulation of AR-2474 was at least as efficacious as mupirocin. Dr. Sergio Lociuro, Head of Research at Arpida Ltd. commented, "AR-2474 originates from our own research discovery programs and has now progressed to an advanced pre-clinical stage of development. We aim to develop AR-2474 as a topical therapy for different indications including the prevention of MRSA transmission. In recent
'"/>




Page: 1 2 3

Related medicine technology :

1. Arpida Announces Promising Results of "First-In-Man" Studies With AR-709
2. Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent porphyria
3. Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Arpida adds novel antibiotic its preclinical pipeline
(Date:11/6/2009)...Newswire/ -- Repossessions and liquidations of tru...rter of 2009 declined as compared to similar figur...,s NasTrac Quarterly Index (NQI). The figures, cu...repossessions and orderly liquidations, also indic... and printing equipment, offering mixed news on th...
(Date:11/6/2009)...wire-USNewswire/ -- America,s Specialty Medicines ...-market and smaller innovator pharmaceutical compa...e "Affordable Health Care for America Act," introd...ler companies fear that the cumulative effect of a... efforts to bring new medicines to market. ,,...
(Date:11/6/2009)...ewswire-FirstCall/ -- Boston Scientific Corporatio...d an agreement in principle with the U.S. Departme...issued by its Guidant subsidiary in 2005. The all...oston Scientific,s 2006 acquisition of Guidant. ,...investigation by the U.S. Attorney,s Office in Min...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Female choice benefits mothers more than offspring 10486 1Female choice benefits mothers more than offspring 10486 2NSF awards Life in Transition grants to University of Oklahoma professors 10484 1NSF awards Life in Transition grants to University of Oklahoma professors 10484 2Cocaine exposure during pregnancy leads to impulsivity in male not female monkeys 59955 1Cocaine exposure during pregnancy leads to impulsivity in male not female monkeys 59955 2Cocaine exposure during pregnancy leads to impulsivity in male not female monkeys 59955 3Cocaine exposure during pregnancy leads to impulsivity in male not female monkeys 59955 4
(Date:11/6/2009)... (NYSE: HSP ), a leading global specialty pharmac...ounced that the company will present at the Piper ...esday, Dec. 2, 2009 in New York City. ,, The prese... time on Wednesday, Dec. 2, 2009. It will be avai...iocast accessible via the investor relations secti...
(Date:11/6/2009)...ed today from Jackson Healthcare reports that the ...they have less control over the way they practice ... Alpharetta, GA (Vocus) November 6,...lthcare reports that the majority of physicians s...ver the way they practice medicine than they did f...
(Date:11/6/2009)...programs, expert says , , FRIDAY, Nov. 6 (...difficult than ever before for many Americans to a...s are available, according to an expert from Butle...r pharmacist, advised Carriann Richey, director of...tice at Butler,s College of Pharmacy and Health Sc...
(Date:11/6/2009)...ue for certain patients, researchers say , ...ntists who used embryonic stem cells to create lun...native to lung transplants for patients with chron...c fibrosis. , This is the first time it,s been sho... airway epithelial-like cells without the use of s...
(Date:11/6/2009)...istakenly inject three public school students with...s, including David Perceman, are only surprised mo...rted. , New York, New Yor...dical malpractice lawyers are unsurprised that th...ublic school nurses without a medical consent form...
Breaking Medicine News(10 mins):Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 2Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 3Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 4Health News: Pay Less for Prescription Drugs 2Health News:New York Medical Malpractice Lawyer Comments on School Nurses Injecting Students with Swine Flu Vaccine without Consent 2Health News:New York Medical Malpractice Lawyer Comments on School Nurses Injecting Students with Swine Flu Vaccine without Consent 3
... changed; Covenants reset for 2008 and 2009 , , T...poration (Nasdaq: PRSC ) today announced it has ... debt holders related to its $173 million senior t... of covenant calculation adjustments that reflect ...
...rs of slumber per night heightened the odds, study... News) -- A good night,s sleep may help lower your...ay. , People averaging less than six hours of shu...ged six to eight hours of sleep, according to rese...
...y showed early signs of cardiovascular trouble , ...n yet another sign that obesity poses health risks...ildren as young as age 3 can begin to show signs o...e 85th percentile or above for their height and ag...
...itehead Institute researchers have pinpointed a ce...umors are susceptible to dietary restriction durin...I3K is permanently turned "on" via mutation, tumor...tiondefined as food consumption limited to 60% of ...
...ls Lauded for Their Commitment to Cleanliness ,...Award from SDA, NEA, CDC , , , WASHINGTON, March...roving school health through cleaning is now in th...p and Detergent Association (SDA - www.cleaning10...
...., March 11 Carolyn M. Clancy, M.D., director of ...day announced the appointment of three new members...n Curry, Ph.D., of Iowa City; Joy Melnikow, M.D., ...onsored by AHRQ, consists of 16 health care expert...
Other Medicine News:Health News:The Providence Service Corporation Announces Credit Agreement Amendment With Its Lender Syndicate 2Health News:The Providence Service Corporation Announces Credit Agreement Amendment With Its Lender Syndicate 3Health News:Too Little Sleep May Raise Diabetes Risk 2Health News:Overweight Preschoolers Raise Their Heart Disease Risk 2Health News:Overweight Preschoolers Raise Their Heart Disease Risk 3Health News:Cell pathway on overdrive prevents cancer response to dietary restriction 2Health News:Cell pathway on overdrive prevents cancer response to dietary restriction 3Health News:Cleaning for Health: Custodians Honored for Improving School Environment 2Health News:Cleaning for Health: Custodians Honored for Improving School Environment 3Health News:AHRQ Announces New Members of the U.S. Preventive Services Task Force 2
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
Medicine Products: